NextGen Sciences this week launched its CSFassay-rat A.1.0 assay for the discovery and quantification in rats of protein biomarkers linked to central nervous system disorders including dementia and Parkinson's.
The assay uses multiple-reaction monitoring mass spectrometry to simultaneously measure 62 proteins in rat cerebrospinal fluid samples.